Financial statements Starkey Laboratories Poland
Balance sheet data of STARKEY LABORATORIES POLAND
|
Year
|
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
|---|---|---|---|---|---|---|
| Total assets | 17 390 771,68 | 20 090 166,02 | 25 171 071,88 | 18 875 924,66 | 13 375 885,11 | 13 868 736,51 |
| A. Fixed assets | 12 627 010,40 | 12 583 720,24 | 13 401 356,14 | 7 904 975,96 | 7 401 221,87 | 7 316 965,74 |
| B. Current assets | 4 763 761,28 | 7 506 445,78 | 11 769 715,74 | 10 970 948,70 | 5 974 663,24 | 6 551 770,77 |
| C. Share capital contributions (basic funds) | - | - | - | - | - | - |
| D. Own shares (stocks) | - | - | - | - | - | - |
| Total liabilities | 17 390 771,68 | 20 090 166,02 | 25 171 071,88 | 18 875 924,66 | 13 375 885,11 | 13 868 736,51 |
| A. Equity | 1 979 141,84 | 1 531 617,59 | 188 847,88 | -6 693 828,46 | 5 571 510,54 | 6 890 539,39 |
| B. Liabilities and provisions for liabilities | 15 411 629,84 | 18 558 548,43 | 24 982 223,99 | 25 569 753,12 | 7 804 374,57 | 6 978 197,12 |
| I. Long-term liabilities | 11 913 178,00 | 12 413 178,00 | 13 913 178,00 | 16 033 178,00 | 0,00 | 252 709,00 |
| II. Short-term liabilities | 2 727 859,23 | 5 252 763,77 | 9 975 517,33 | 8 656 623,93 | 6 753 928,55 | 5 689 512,95 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.